SCHEMBL19668024

SCHEMBL19668024

Cc1cc(C)c(NC(=O)Nc2ccc3c(c2)OC(F)(F)O3)c(C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.64
MAPT P10636 3/20 0.51
TP53 P04637 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
RECQL P46063 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
NPC1 O15118 6/20 0.45
RAB9A P51151 6/20 0.45
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.41
BRAF P15056 2/20 0.41
SHMT2 P34897 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19668020 0.86 RAB9A (0.51) ATMMAPTTP53SMN1; SMN2RECQL
SCHEMBL19668353 0.82 ADORA3 (0.48) ATMMAPTSMN1; SMN2RECQLADORA3
SCHEMBL31317846 0.82 ADORA3 (0.48) ATMMAPTSMN1; SMN2RECQLADORA3
SCHEMBL19678085 0.79 KIT (0.56) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL26633294 0.78 ADORA3 (0.51) MAPTSMN1; SMN2RECQLADORA3ADORA2A
SCHEMBL4057629 0.78 NPC1 (0.61) MAPTSMN1; SMN2ADORA3NPC1RAB9A
SCHEMBL15553344 0.77 BRAF (0.58) MAPTSMN1; SMN2RECQLADORA3ADORA2A
SCHEMBL4053608 0.76 EPHX2 (0.61) MAPTSMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL4053993 0.73 MAPT (0.62) MAPTTP53SMN1; SMN2NPC1RAB9A
SCHEMBL4448022 0.72 ALDH1A1 (0.65) ATMMAPTTP53ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187696-B2 Urea motif containing compounds and derivatives thereof as antibacterial drugs Technische Universität München (DE) 2025-01-07 US disclosed
EP-3464260-B1 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS UNIV MUENCHEN TECH (DE) 2021-10-27 EP disclosed
EP-3464260-B1 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS UNIV MUENCHEN TECH (DE) 2021-10-27 EP disclosed
US-20210009550-A1 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS Technische Universität München (DE) 2021-01-14 US disclosed
US-20210009550-A1 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS Technische Universität München (DE) 2021-01-14 US disclosed
EP-3464260-A2 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS Technische Universität München (DE) 2019-04-10 EP disclosed
WO-2017207556-A2 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS Technische Universität München (DE) 2017-12-07 WO disclosed
WO-2017207556-A2 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS Technische Universität München (DE) 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009550-A1 UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS UMPS, UNG, UFM1 ATM 3115/4885MAPT 1892/4885TP53 1363/4885
US-12187696-B2 Urea motif containing compounds and derivatives thereof as antibacterial drugs UMPS, UNG, UFM1 ATM 3115/4885MAPT 1892/4885TP53 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.